{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:35:10Z","timestamp":1782387310387,"version":"3.54.5"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Session 1 of the 2009 Workshop of the Society for Hematopathology\/European Association of Haematopathology, Cleveland, OH, focused on plasma cell neoplasms. This report summarizes the salient diagnostic, clinical, and genetic features of plasma cell myeloma (PCM) and related neoplasms. Based on the cases submitted to the workshop, we highlight common diagnostic issues and unusual manifestations of plasma cell neoplasms, such as t(11;14)+ PCM, plasma cell leukemia, and nonsecretory plasmacytoma, as well as plasmablastic transformation of PCM. Additional issues repeatedly raised at the workshop included the differential diagnosis of extramedullary dissemination of PCM vs primary extramedullary plasmacytoma and plasmablastic lymphoma; systemic plasma cell neoplasms in immunocompromised people; and Epstein-Barr virus\u2013associated plasma cell neoplasms. Difficult cases with borderline features presented by submitters emphasized the necessity of integrating clinical, immunophenotypic, and genetic features for appropriate classification of these disorders.<\/jats:p>","DOI":"10.1309\/ajcpenj68ffbriyb","type":"journal-article","created":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T16:42:07Z","timestamp":1310661727000},"page":"168-182","source":"Crossref","is-referenced-by-count":97,"title":["Plasma Cell Myeloma and Related Neoplasms"],"prefix":"10.1093","volume":"136","author":[{"given":"Robert B.","family":"Lorsbach","sequence":"first","affiliation":[{"name":"1Department of Pathology, University of Arkansas for Medical Sciences, Little Rock"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[{"name":"2Department of Clinical Pathology, Cleveland Clinic, Cleveland OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[{"name":"3Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[{"name":"4Institute of Pathology, University Hospital Tuebingen, Eberhard-Karls University, Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,8,1]]},"reference":[{"key":"2023012002400708200_b1-1360168","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.beha.2007.08.004","article-title":"Genetic events in the pathogenesis of multiple myeloma","volume":"20","author":"Chng","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"2023012002400708200_b2-1360168","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1200\/JCO.2005.05.021","article-title":"Molecular pathogenesis and a consequent classification of multiple myeloma","volume":"23","author":"Bergsagel","year":"2005","journal-title":"J Clin Oncol"},{"key":"2023012002400708200_b3-1360168","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood.V98.10.3082","article-title":"Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors","volume":"98","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"key":"2023012002400708200_b4-1360168","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.97.1.228","article-title":"Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma","volume":"97","author":"Shou","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023012002400708200_b5-1360168","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1097-0142(197908)44:2<630::AID-CNCR2820440233>3.0.CO;2-G","article-title":"Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders","volume":"44","author":"Liang","year":"1979","journal-title":"Cancer"},{"key":"2023012002400708200_b6-1360168","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V88.2.674.bloodjournal882674","article-title":"Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines","volume":"88","author":"Chesi","year":"1996","journal-title":"Blood"},{"key":"2023012002400708200_b7-1360168","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1309\/4W8E-8F4K-BHUP-UBE7","article-title":"The (11;14) (q13;q32) translocation in multiple myeloma: a morphologic and immunohistochemical study","volume":"113","author":"Hoyer","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"2023012002400708200_b8-1360168","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1309\/BDR959TT4JU6388C","article-title":"Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival","volume":"125","author":"Cook","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"2023012002400708200_b9-1360168","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"2023012002400708200_b10-1360168","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.leukres.2007.05.021","article-title":"Cyclin D1 positive multiple myeloma: predominance of the short, 3\u2019UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions","volume":"32","author":"Slotta-Huspenina","year":"2008","journal-title":"Leuk Res"},{"key":"2023012002400708200_b11-1360168","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2002-11-3333","article-title":"CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma","volume":"102","author":"Robillard","year":"2003","journal-title":"Blood"},{"key":"2023012002400708200_b12-1360168","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1309\/2A0FL1HM5PN2510P","article-title":"Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients","volume":"123","author":"Lin","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"2023012002400708200_b13-1360168","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.2007.06969.x","article-title":"IgM myeloma: a rare entity characterized by a CD20\u2013CD56\u2013CD117\u2013 immunophenotype and the t(11;14)","volume":"140","author":"Feyler","year":"2008","journal-title":"Br J Haematol"},{"key":"2023012002400708200_b14-1360168","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"key":"2023012002400708200_b15-1360168","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V97.9.2900","article-title":"Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma","volume":"97","author":"Drayson","year":"2001","journal-title":"Blood"},{"key":"2023012002400708200_b16-1360168","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1073\/pnas.87.20.8135","article-title":"A single amino acid substitution in the variable region of the light chain specifically blocks immunoglobulin secretion","volume":"87","author":"Dul","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023012002400708200_b17-1360168","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2004-02-0477","article-title":"A molecular basis for nonsecretory myeloma","volume":"104","author":"Coriu","year":"2004","journal-title":"Blood"},{"key":"2023012002400708200_b18-1360168","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood.V97.3.822","article-title":"Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique","volume":"97","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"key":"2023012002400708200_b19-1360168","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2002-08-2436","article-title":"Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants","volume":"101","author":"Avet-Loiseau","year":"2003","journal-title":"Blood"},{"key":"2023012002400708200_b20-1360168","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/leu.2008.4","article-title":"Genetic aberrations and survival in plasma cell leukemia","volume":"22","author":"Tiedemann","year":"2008","journal-title":"Leukemia"},{"key":"2023012002400708200_b21-1360168","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0046-8177(99)90166-1","article-title":"Crystal-storing histiocytosis: a disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain","volume":"30","author":"Jones","year":"1999","journal-title":"Hum Pathol"},{"key":"2023012002400708200_b22-1360168","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V100.5.1817.h81702001817_1817_1827","article-title":"Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature","volume":"100","author":"Lebeau","year":"2002","journal-title":"Blood"},{"key":"2023012002400708200_b23-1360168","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1309\/5EL22BH45PHUPM8P","article-title":"Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma","volume":"127","author":"Seegmiller","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"2023012002400708200_b24-1360168","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2009.34","article-title":"Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"22","author":"Morice","year":"2009","journal-title":"Mod Pathol"},{"key":"2023012002400708200_b25-1360168","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2141.1985.tb02963.x","article-title":"The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patients","volume":"59","author":"Brouet","year":"1985","journal-title":"Br J Haematol"},{"key":"2023012002400708200_b26-1360168","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood.V66.2.291.291","article-title":"Associated chronic lymphocytic leukemia and multiple myeloma: origin from a single clone","volume":"66","author":"Fermand","year":"1985","journal-title":"Blood"},{"key":"2023012002400708200_b27-1360168","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s002770100328","article-title":"Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma: a report on two cases","volume":"80","author":"Kaufmann","year":"2001","journal-title":"Ann Hematol"},{"key":"2023012002400708200_b28-1360168","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0165-4608(03)00217-6","article-title":"Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin","volume":"148","author":"Chang","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"2023012002400708200_b29-1360168","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/leu.2009.294","article-title":"Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma","volume":"24","author":"Pantic","year":"2010","journal-title":"Leukemia"},{"key":"2023012002400708200_b30-1360168","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.133.5.813","article-title":"Plasma cell leukemia: report on 17 cases","volume":"133","author":"Kyle","year":"1974","journal-title":"Arch Intern Med"},{"key":"2023012002400708200_b31-1360168","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2141.1994.tb05114.x","article-title":"Primary plasma cell leukaemia","volume":"88","author":"Dimopoulos","year":"1994","journal-title":"Br J Haematol"},{"key":"2023012002400708200_b32-1360168","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood.V93.3.1032","article-title":"Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics","volume":"93","author":"Garcia-Sanz","year":"1999","journal-title":"Blood"},{"key":"2023012002400708200_b33-1360168","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ajh.20272","article-title":"Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature","volume":"78","author":"Saccaro","year":"2005","journal-title":"Am J Hematol"},{"key":"2023012002400708200_b34-1360168","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jjco\/hyg043","article-title":"A case of primary plasma cell leukemia with hairy-cell morphology and lambda-type Bence-Jones protein: immunohistochemical and molecular analysis","volume":"33","author":"Tanioka","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"2023012002400708200_b35-1360168","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.leu.2401211","article-title":"The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma","volume":"12","author":"Pellat-Deceunynck","year":"1998","journal-title":"Leukemia"},{"key":"2023012002400708200_b36-1360168","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.leu.2402116","article-title":"Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization","volume":"15","author":"Gutierrez","year":"2001","journal-title":"Leukemia"},{"key":"2023012002400708200_b37-1360168","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/gcc.20670","article-title":"Frequent upregulation of MYC in plasma cell leukemia","volume":"48","author":"Chiecchio","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"2023012002400708200_b38-1360168","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2141.2004.04834.x","article-title":"Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma","volume":"124","author":"Soutar","year":"2004","journal-title":"Br J Haematol"},{"key":"2023012002400708200_b39-1360168","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2008.07421.x","article-title":"Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992\u20132004","volume":"144","author":"Dores","year":"2009","journal-title":"Br J Haematol"},{"key":"2023012002400708200_b40-1360168","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2407-6-118","article-title":"Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study","volume":"6","author":"Knobel","year":"2006","journal-title":"BMC Cancer"},{"key":"2023012002400708200_b41-1360168","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2141.2009.07637.x","article-title":"Prognostic factors influencing survival in solitary plasmacytoma","volume":"145","author":"Ramsingh","year":"2009","journal-title":"Br J Haematol"},{"key":"2023012002400708200_b42-1360168","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/path.1680","article-title":"Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis","volume":"205","author":"Kremer","year":"2005","journal-title":"J Pathol"},{"key":"2023012002400708200_b43-1360168","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3324\/haematol.12005","article-title":"Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics","volume":"93","author":"Bink","year":"2008","journal-title":"Haematologica"},{"key":"2023012002400708200_b44-1360168","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2141.1982.tb02791.x","article-title":"Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging","volume":"51","author":"Bartl","year":"1982","journal-title":"Br J Haematol"},{"key":"2023012002400708200_b45-1360168","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ajcp\/87.3.342","article-title":"Histologic classification and staging of multiple myeloma: a retrospective and prospective study of 674 cases","volume":"87","author":"Bartl","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"2023012002400708200_b46-1360168","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V65.2.305.305","article-title":"Multiple myeloma: significance of plasmablastic subtype in morphological classification","volume":"65","author":"Greipp","year":"1985","journal-title":"Blood"},{"key":"2023012002400708200_b47-1360168","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood.V91.7.2501","article-title":"Plasmablastic morphology: an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) Myeloma Trial E9486 report by the ECOG Myeloma Laboratory Group","volume":"91","author":"Greipp","year":"1998","journal-title":"Blood"},{"key":"2023012002400708200_b48-1360168","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1200\/JCO.1999.17.5.1551","article-title":"Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma","volume":"17","author":"Rajkumar","year":"1999","journal-title":"J Clin Oncol"},{"key":"2023012002400708200_b49-1360168","first-page":"2119","article-title":"Correlations between karyotype and cytologic findings in multiple myeloma","volume":"9","author":"Weh","year":"1995","journal-title":"Leukemia"},{"key":"2023012002400708200_b50-1360168","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1182\/blood-2009-01-202010","article-title":"Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone","volume":"114","author":"Kapoor","year":"2009","journal-title":"Blood"},{"key":"2023012002400708200_b51-1360168","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1182\/blood-2008-12-193458","article-title":"Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13","volume":"114","author":"Reece","year":"2009","journal-title":"Blood"},{"key":"2023012002400708200_b52-1360168","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2141.2002.03401.x","article-title":"Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations","volume":"117","author":"Fassas","year":"2002","journal-title":"Br J Haematol"},{"key":"2023012002400708200_b53-1360168","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"2023012002400708200_b54-1360168","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.170.5.1715","article-title":"Ras oncogene mutation in multiple myeloma","volume":"170","author":"Neri","year":"1989","journal-title":"J Exp Med"},{"key":"2023012002400708200_b55-1360168","first-page":"2539","article-title":"p53 and RAS gene mutations in multiple myeloma","volume":"7","author":"Portier","year":"1992","journal-title":"Oncogene"},{"key":"2023012002400708200_b56-1360168","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood.V88.7.2699.bloodjournal8872699","article-title":"Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial","volume":"88","author":"Liu","year":"1996","journal-title":"Blood"},{"key":"2023012002400708200_b57-1360168","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V92.3.802","article-title":"Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy","volume":"92","author":"Drach","year":"1998","journal-title":"Blood"},{"key":"2023012002400708200_b58-1360168","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2141.1999.01615.x","article-title":"p53 deletion is not a frequent event in multiple myeloma","volume":"106","author":"Avet-Loiseau","year":"1999","journal-title":"Br J Haematol"},{"key":"2023012002400708200_b59-1360168","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/humu.1177","article-title":"High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis","volume":"18","author":"Bezieau","year":"2001","journal-title":"Hum Mutat"},{"key":"2023012002400708200_b60-1360168","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood-2004-04-1363","article-title":"p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation","volume":"105","author":"Chang","year":"2005","journal-title":"Blood"},{"key":"2023012002400708200_b61-1360168","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3324\/haematol.2008.004440","article-title":"Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case","volume":"94","author":"Chiecchio","year":"2009","journal-title":"Haematologica"},{"key":"2023012002400708200_b62-1360168","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group Molecular Classification of Multiple Myeloma: spotlight review","volume":"23","author":"Fonseca","year":"2009","journal-title":"Leukemia"},{"key":"2023012002400708200_b63-1360168","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene"},{"issue":"suppl 1","key":"2023012002400708200_b64-1360168","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/annonc\/11.suppl_1.S131","article-title":"Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma","volume":"11","author":"Chesi","year":"2000","journal-title":"Ann Oncol"},{"key":"2023012002400708200_b65-1360168","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"2023012002400708200_b66-1360168","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"2023012002400708200_b67-1360168","first-page":"503","article-title":"Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus","volume":"8","author":"Aguilera","year":"1995","journal-title":"Mod Pathol"},{"key":"2023012002400708200_b68-1360168","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1309\/27H8XJH31F3GUNAT","article-title":"Plasmablastic cytomorphologic features in plasma cell neoplasms in immunocompetent patients are significantly associated with EBV","volume":"128","author":"Chang","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"2023012002400708200_b69-1360168","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1309\/AJCPFUR1BK0UODTS","article-title":"Plasmablastic lymphomas with MYC\/IgH rearrangement: report of three cases and review of the literature","volume":"132","author":"Bogusz","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"2023012002400708200_b70-1360168","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/modpathol.2010.72","article-title":"Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features [published online ahead of print March 26, 2010]","volume":"23","author":"Taddesse-Heath","year":"2010","journal-title":"Mod Pathol"},{"key":"2023012002400708200_b71-1360168","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.pas.0000173023.02724.1f","article-title":"Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus\u2013associated extramedullary plasmacytic neoplasm","volume":"29","author":"Dong","year":"2005","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/136\/2\/168\/48790701\/ajcp_136_2_168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/136\/2\/168\/48790701\/ajcp_136_2_168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T02:41:02Z","timestamp":1674182462000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/136\/2\/168\/1765846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,1]]},"references-count":71,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,8,1]]},"published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpenj68ffbriyb","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,8,1]]},"published":{"date-parts":[[2011,8,1]]}}}